Markets:

Overview

News

Currencies

International

Treasuries

bluebird bio, Inc. - Common Stock (NQ:BLUE)

4.970 UNCHANGED

Last Price Updated: 4:00 PM EDT, May 30, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about bluebird bio, Inc. - Common Stock

< Previous 1 2

...

7 8 9 10 11 12 13 14 Next >

Where bluebird bio Stands With Analysts ↗

January 06, 2022

Within the last quarter, bluebird bio (NASDAQ:BLUE) has observed the follow...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

December 29, 2021

Gainers Cognition Therapeutics (NASDAQ:CGTX

Via Benzinga

Mid-Day Market Update: Crude Oil Drops Over 5%; Society Pass Shares Jump ↗

December 20, 2021

Midway through trading Monday, the Dow traded down 1.78% to 34,735.33 while the NASDAQ fell 1.43% to 14,952.69. The S&P also fell, dropping 1.59% to 4,547.26. The U.S. has the...

Via Benzinga

38 Stocks Moving In Monday's Mid-Day Session ↗

December 20, 2021

Gainers Society Pass Incorporated (NASDAQ: SOPA) shares jumped 120.9% to $7.31 after the company reported addition to the Russell 2000 Index. Can-Fite BioPharma Ltd. (NYSE: CANF...

Via Benzinga

Why Are Bluebird Bio Shares Trading Lower Today? ↗

December 20, 2021

The FDA has placed a partial clinical hold on Bluebird bio Inc's (NASDAQ: BLUE) lovotibeglogene autotemcel (lovo-cel) gene therapy program for sickle cell...

Via Benzinga

Bluebird bio's Neurodegenerative Disease Gene Therapy Under Priority FDA Review, Despite Clinical Hold ↗

December 20, 2021

The FDA has accepted for priority review Buebird bio Inc's (NASDAQ: BLUE) marketing application for elivaldogene autotemcel (eli-cel, Lenti-D) for cerebral...

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

December 13, 2021

Gainers Arena Pharmaceuticals (NASDAQ:ARNA) stock moved upwards by 91.22% to $95.5 during Monday's pre-market session. The company's market cap stands at $5.8...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

December 13, 2021

Welcome back, investor! With our return from the weekend comes a dive into the biggest pre-market stock movers for Monday!

Via InvestorPlace

New Data At ASH21 Show Bluebird's Thalassemia Gene Therapy Potentially Curative One-Time Treatment ↗

December 13, 2021

Bluebird Bio Inc (NASDAQ: BLUE) presented new results for betibeglogene autotemcel (beti-cel), investigational gene therapy for β-thalassemia (beta-thal) who...

Via Benzinga

Bluebird Bio Posts Updated Data From Sickle Cell Gene Therapy Program ↗

December 13, 2021

Bluebird bio Inc (NASDAQ: BLUE) announced updated results from its Phase 1/2 HGB-206 study of lovotibeglogene autotemcel (lovo-cel; formerly LentiGlobin for SCD,...

Via Benzinga

22 Stocks Moving in Monday's Pre-Market Session ↗

December 13, 2021

Gainers Petros Pharmaceuticals, Inc. (NASDAQ: PTPI) rose 32.6% to $3.58 in pre-market trading after gaining more than 14% on Friday. Foghorn Therapeutics Inc. (NASDAQ: FHTX) rose...

Via Benzinga

The Week Ahead In Biotech (Dec. 12-18): Hematology Conference Presentations, FDA Decisions For Calliditas, Argenx, Intra-Cellular & Eagle Pharma And More ↗

December 12, 2021

Biotech stocks closed out the week ending Dec. 10 with modest losses as investors moved money out of defensives and into risky bets amid the broader market rebound. Multiple...

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

November 22, 2021

Gainers iSpecimen (NASDAQ:ISPC) stock rose 31.09% to $6.45 during Monday's pre-market session. The company's market cap stands at $44.9 million. Provention Bio (...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

November 22, 2021

Welcome back, traders! We're getting right into the week with a breakdown of the biggest pre-market stock movers for Monday!

Via InvestorPlace

Bluebird Bio's Thalassemia Gene Therapy Under Priority Review With FDA ↗

November 22, 2021

The FDA has accepted Bluebird bio Inc's (NASDAQ: BLUE) marketing application for betibeglogene autotemcel (beti-cel) for β-thalassemia. The agency has...

Via Benzinga

Why Bluebird Bio Stock Plunged Today ↗

November 08, 2021

Two analysts downgraded the biotech stock.

Via The Motley Fool

64 Biggest Movers From Yesterday ↗

November 09, 2021

Gainers Pioneer Power Solutions, Inc. (NASDAQ: PPSI) shares jumped 219% to close at $10.40 on Monday after the company announced the launch of its E-Boost portfolio of mobile...

Via Benzinga

Market Rally Continues as Dow Nabs Intraday Highs ↗

November 08, 2021

S&P 500 Index and Nasdaq Composite are sporting modest gains, with the Dow locking in another fresh intraday high.

Via Talk Markets

Topics Stocks

38 Stocks Moving In Monday's Mid-Day Session ↗

November 08, 2021

Gainers Pioneer Power Solutions, Inc. (NASDAQ: PPSI) shares climbed 129.8% to $7.49 after the company announced the launch of its E-Boost portfolio of mobile Electric Vehicle...

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

November 08, 2021

Gainers PetVivo Holdings (NASDAQ:PETV) s...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For November 8, 2021 ↗

November 08, 2021

Upgrades For Nektar Therapeutics (NASDAQ:

Via Benzinga

92 Biggest Movers From Friday ↗

November 08, 2021

Gainers Mainz Biomed B.V. (NASDAQ: MYNZ) shares jumped 99.8% to close at $9.99 on Friday. Mainz Biomed priced its initial public offering of 2 million ordinary shares at $5, the...

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

November 05, 2021

Gainers Chinook Therapeutics (NASDAQ:KDNY) shares increased by 28.75% to $15.76 during Friday's regular session. Trading volume for this security as of 12:30 EST is 1....

Via Benzinga

64 Stocks Moving In Friday's Mid-Day Session ↗

November 05, 2021

Gainers Mainz Biomed B.V. (NASDAQ: MYNZ) shares climbed 198.4% to $14.92. Mainz Biomed priced its initial public offering of 2 million ordinary shares at $5, the middle of the...

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

November 05, 2021

Gainers Ontrak (NASDAQ:OTRK) shares rose 21.82% to $11.78 during Friday's pre-market session. The market value of their outstanding shares is at $225.5 million. As per...

Via Benzinga

28 Stocks Moving in Friday's Pre-Market Session ↗

November 05, 2021

Gainers ReWalk Robotics Ltd. (NASDAQ: RWLK) rose 65.8% to $2.14 in pre-market trading after the company announced its ReBoot device has been granted designation as a Breakthrough...

Via Benzinga

Bluebird Bio To Withdraw Marketing Of Skysona Gene Therapy In Europe ↗

October 21, 2021

Bluebird Bio Inc (NASDAQ: BLUE) will withdraw the regulatory marketing authorization for Skysona (elivaldogene autotemcel) in the European Union. The update comes...

Via Benzinga

Could This Beaten-Down Biotech Stock Be the Next Buyout Target? ↗

October 20, 2021

This gene-therapy specialist may need some help turning things around.

Via The Motley Fool

Bluebird Bio or Heron Therapeutics: Which Stock Is the Better Comeback Play? ↗

October 11, 2021

These once-promising biotech stocks are trading at a fraction of their all-time highs right now.

Via The Motley Fool

The Daily Biotech Pulse: Pfizer-BioNTech US Vaccine Contract, Summit Slumps On Adverse Regulatory Feedback, Cerevel CFO Departs ↗

September 22, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 20) Acceleron Pharma Inc. (...

Via Benzinga

< Previous 1 2

...

7 8 9 10 11 12 13 14 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

bluebird bio, Inc. - Common Stock (NQ:BLUE)

Headline News about bluebird bio, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today